Inhibition of VEGFR2 and EGFR signaling cooperatively suppresses the proliferation of oral squamous cell carcinoma

BACKGROUND: Epidermal growth factor receptor (EGFR) is frequently overexpressed in oral squamous cell carcinoma (OSCC), and EGFR‐targeting therapeutics have been widely employed to treat patients with a variety of carcinomas including OSCC. Here, we aimed to investigate alternative signaling for OSC...

Descripción completa

Detalles Bibliográficos
Autores principales: Onda, Maho, Ota, Akinobu, Ito, Kunihiro, Ono, Takayuki, Karnan, Sivasundaram, Kato, Mikako, Kondo, Sayuri, Furuhashi, Akifumi, Hayashi, Tomio, Hosokawa, Yoshitaka, Kazaoka, Yoshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469792/
https://www.ncbi.nlm.nih.gov/pubmed/37341071
http://dx.doi.org/10.1002/cam4.6282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469792/
https://www.ncbi.nlm.nih.gov/pubmed/37341071
http://dx.doi.org/10.1002/cam4.6282

Ejemplares similares